Evidence map›Paper›PMID 33921005›Full record

ArticleNanomaterials (Basel, Switzerland)2021

Enhanced Mechanical, Thermal and Antimicrobial Properties of Additively Manufactured Polylactic Acid with Optimized Nano Silica Content.

Nectarios Vidakis, Markos Petousis, Emanuel Velidakis, Nikolaos Mountakis, Lazaros Tzounis, Marco Liebscher, Sotirios A Grammatikos

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. The Effect of Nano Zirconium Dioxide (ZrONanomaterials (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Nectarios VidakisMechanical Engineering Department, Hellenic Mediterranean University, 71410 Heraklion, Greece.
Markos PetousisMechanical Engineering Department, Hellenic Mediterranean University, 71410 Heraklion, Greece.ORCID 0000-0003-1312-7898
Emanuel VelidakisMechanical Engineering Department, Hellenic Mediterranean University, 71410 Heraklion, Greece.
Nikolaos MountakisMechanical Engineering Department, Hellenic Mediterranean University, 71410 Heraklion, Greece.
Lazaros TzounisDepartment of Materials Science and Engineering, University of Ioannina, 45110 Ioannina, Greece.
Marco LiebscherInstitute of Construction Materials, Technische Universität Dresden, DE-01062 Dresden, Germany.ORCID 0000-0003-4054-6414
Sotirios A GrammatikosDepartment of Manufacturing & Civil Engineering, NTNU-Norwegian University of Science and Technology, Building B', Teknologivegen 22, 2815 Gjøvik, Norway.ORCID 0000-0003-1430-6089
Hellenic Mediterranean University · GRNorwegian University of Science and Technology · NOTechnische Universität Dresden · DEUniversity of Ioannina · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The scope of this work was to create, with melt mixing compounding process, novel nanocomposite filaments with enhanced properties that industry can benefit from, using commercially available materials, to enhance the performance of three-dimensional (3D) printed structures fabricated via fused filament fabrication (FFF) process. Silicon Dioxide (SiO

Indexed as

additive manufacturing (AM)Charpy’s impact testflexural testnanocompositespolylactic acid (PLA)scanning electron microscopy (SEM)silicone dioxide (SiO2)tensile testthree-dimensional (3D) printingVickers microhardness

Identifiers

PMID33921005
PMCPMC8071401
OpenAlexW3155931756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.